Source: Annual Congress 2006 - Epidemiology of drug resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. A. Budnik, L. K. Surkova, A. P. Astrauko, A. M. Zalutskaya (Minsk, Belarus). MDR tuberculosis as the principal cause of death. Eur Respir J 2006; 28: Suppl. 50, 189

Member's Comments

No comment yet.

Related content which might interest you: The main causes which are responsible for secondary chemoresistance of Mycobacterium tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 Unrevealed lung tuberculosis as the reason of death Source: Eur Respir J 2004; 24: Suppl. 48, 419s Year: 2004 Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 The burden of childhood and adult tuberculosis, including MDR and TDR TB Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Treatment‘s side effects in MDR tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005 Neutrophilia independently predicts death in tuberculosis Source: Eur Respir J 2013; 42: 1752-1757 Year: 2013 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Problems in reporting cause of death in patients with tuberculosis (TB) Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Our experience in multi drug resistant tuberculosis (MDR TB) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis Source: Eur Respir J 2013; 41: 1393-1400 Year: 2013 Multidrug resistance influence on tuberculosis mortality and lethal outcome in prisons of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 425s Year: 2007 Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB Source: Eur Respir J 2009; 33: 1085-1094 Year: 2009 Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009 Artificial pneumothorax in the treatment of multi drug resistant tuberculosis (MDR TB) Source: Eur Respir J 2006; 28: Suppl. 50, 586s Year: 2006 Risk factors for treatment failure in multidrug-resistant and extensively drug-resistant tuberculosis in Estonia Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Management of MDR tuberculosis Source: Short video discussion 2021 Year: 2021 The WHO strategy for TB control and elimination Source: Eur Respir Mon 2012; 58: 242-253 Year: 2012 Clinical and operational value of the extensively drug-resistant tuberculosis definition Source: Eur Respir J 2007; 30: 623-626 Year: 2007 Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Latent tuberculosis infection as a cause of tuberculosis disease Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003